Cushing's Disease: Failure of Treatment with Cyproheptadine

Overview

Journal Br Med J

Specialty General Medicine

Date 1977 Mar 12

PMID 843872

Citations 5

Authors

J Allgrove

P Husband

C G Brook

Affiliations

Soon will be listed here.

Citing Articles

The Treatment of Cushing's Disease.

Pivonello R, de Leo M, Cozzolino A, Colao A Endocr Rev. 2015; 36(4):385-486.

PMID: 26067718 PMC: 4523083. DOI: 10.1210/er.2013-1048.

Cyproheptadine treatment in Cushing's disease.

Tanakol R, Alagol F, Azizlerli H, SANDALCI O, Terzioglu T, BERKER F J Endocrinol Invest. 1996; 19(4):242-7.

PMID: 8862505 DOI: 10.1007/BF03349875.

Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.

Ishibashi M, Yamaji T J Clin Invest. 1981; 68(4):1018-27.

PMID: 6270192 PMC: 370889. DOI: 10.1172/jci110324.

Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.

Ooi T J Endocrinol Invest. 1987; 10(2):107-9.

PMID: 3584851 DOI: 10.1007/BF03347166.

Cushing's disease presenting with growth failure: clinical remission during cyproheptadine therapy.

Grant D, ATHERDEN S Arch Dis Child. 1979; 54(6):466-8.

PMID: 475431 PMC: 1545428. DOI: 10.1136/adc.54.6.466.

References

Krieger D, Amorosa L, Linick F . Cyproheptadine-induced remission of Cushing's disease. N Engl J Med. 1975; 293(18):893-6. DOI: 10.1056/NEJM197510302931802. View

Plonk J, Bivens C, Feldman J . Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine. J Clin Endocrinol Metab. 1974; 38(5):836-40. DOI: 10.1210/jcem-38-5-836. View